BMO MSCI Genomic Innovation ETF (DELISTED) (ZGEN.TO:DL)
18.00
0.00 (0.00%)
CAD |
TSX |
Jan 04, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.45% | -0.41% | 2.946M | -- |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | 200.0% | -789103.7 | Upgrade |
Basic Info
| Investment Strategy | |
| BMO MSCI Genomic Innovation ETF seeks to replicate, to the extent possible, the performance of an innovative genomic companies index, net of expenses. Currently, BMO MSCI Genomic Innovation ETF seeks to replicate the performance of the MSCI ACWI IMI Genomic Innovations Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | Morningstar Gbl GR CAD |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | BMO Asset Management Inc |
| Prospectus Benchmark Index | |
| MSCI ACWI IMI GENOMIC INNOVATION NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 2.86 yrs |
Performance Versus Category
Annual Total Returns Versus Peers
As of January 04, 2024.
Basic Info
| Investment Strategy | |
| BMO MSCI Genomic Innovation ETF seeks to replicate, to the extent possible, the performance of an innovative genomic companies index, net of expenses. Currently, BMO MSCI Genomic Innovation ETF seeks to replicate the performance of the MSCI ACWI IMI Genomic Innovations Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | Morningstar Gbl GR CAD |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | -- |
| Fund Owner Firm Name | BMO Asset Management Inc |
| Prospectus Benchmark Index | |
| MSCI ACWI IMI GENOMIC INNOVATION NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 2.86 yrs |